52 AIM-Mar26314 Developing an innovative product is one challenge. Manufacturing it consistently under cleanroom conditions, at high volumes, and with stable quality over years of production is another. This is where Contract Development and Manufacturing Organisation (CDMO) Weidmann Medical Technology focuses its expertise: combining precision molding, automation, inline quality assurance, and scalable manufacturing into robust production systems. We heard more from Florian Lehner below, Director of Business Development, as the CDMO is named in the Healthcare and Pharmaceutical Awards 2026. “Even highly automated manufacturing processes serve a much bigger purpose: ensuring that medical products perform reliably when patient health depends on them.” Weidmann Medical Technology is a specialised CDMO for highprecision, injection-moulded components, and automated assembly solutions for the medical, pharmaceutical, and Precision Medical Manufacturing CDMO of the Year 2026 – Switzerland diagnostics industries. The company leverages state-of-theart cleanroom production and expertise in complex plastic components to provide scalable, high-quality solutions. With a focus on the industrialisation of sophisticated plastic components for high-volume production, Weidmann Medical Technology’s edge lies in combining high-volume manufacturing capability, extremely tight tolerances, advanced automation, and integrated inline quality control. It also boasts strong expertise in overmoulding, insert moulding, automated assembly, inline inspection, and RFID-integrated medical components. A pure CDMO, Weidmann Medical Technology does not produce its own medical products and will therefore never compete with its customers. Conversely, it aims to serve its clients as a trusted partner for sophisticated, high-quality injection-moulding components in the medical field, ultimately contributing to better patient health. As part of the Weidmann Group, the company combines the agility of a focused medical technology CDMO with the stability and engineering culture of a globally active industrial company. One of its key strengths lies in its ability to connect development and industrialisation early in the process; through DfM and DfA, the team helps customers optimise products not only for functionality, but also for stable and scalable manufacturing. Furthermore, engineering, innovation, production, and project management teams work very closely together in day-today business at Weidmann Medical Technology. Although the company is a core part of a global industrial group, collaboration remains direct and highly efficient throughout the organisation, which plays a fundamental role in shortening feedback loops between development, production, and automation teams. “Our Swiss engineering expertise, combined with global manufacturing capabilities, ensures efficiency, accuracy, and scalable production for demanding medical applications..” Meeting the challenges of modern medical manufacturing At present, the medical manufacturing industry is facing several parallel challenges: increasing regulatory and documentation requirements; shorter product life cycles and faster industrialisation timelines; geopolitical uncertainty affecting supply chains and raw material markets; and continued pressure on costs and capital-intensive production environments. Therefore, Weidmann Medical Technology has placed its focus upon projects where technical complexity and long-term partnership potential align well. These are typically long-term programmes where process capability and manufacturing reliability are business-critical, often requiring advanced moulding expertise, automation, cleanroom manufacturing, and stable high-volume production.
RkJQdWJsaXNoZXIy MTUyMDQwMA==